Wednesday, October 22, 2014 Last update: 6:33 PM - Covering Large & Obscure Tech Companies Since 1996

Darren Schulte, MD, Appointed CEO of Apixio

Companies mentioned in this article: Apixio Inc.

SAN MATEO, Calif. -- (BUSINESS WIRE) -- Apixio Inc., announced today that its board of directors has appointed Darren Schulte, MD, previously the company’s president, to be chief executive officer. Schulte is replacing the current CEO and co-founder Shawn Dastmalchi, PhD, who will remain as an active board member.

Schulte has been with Apixio for nearly three years serving as chief medical officer and as president. Under Schulte’s leadership of Apixio’s go-to-market efforts, Apixio commercialized its risk adjustment solution, HCC Optimizer; significantly grew its customer base and revenue; and established itself as a pioneer in applying Big Data analytics for risk adjustment.

“I am very confident in Darren’s ability to lead Apixio and to achieve our overall vision,” said Dastmalchi. “Over the last few years I have had the pleasure of working with him closely as his operational responsibilities for the company have expanded. I look forward to continuing to work with Darren as an advisor and a board member.”

Dastmalchi helped establish Apixio in 2009 when increasing electronic health record adoption accelerated the creation of digital clinical data. With his vision and guidance, Apixio created a Big Data platform, the Clinical Knowledge Exchange (CKX), designed to unlock new insights from textual and coded data for clinical, quality, and cost improvement. The CKX platform powers the company’s HCC Optimizer product.

“I am excited to take Apixio through its next phase of growth. Shawn has helped provide a firm foundation for our future,” said Schulte. “Demand for our risk adjustment solution is strong as a result of increasing Medicare Advantage and commercial plan enrollment. Our executive team is a talented and seasoned group of individuals capable of enhancing our market leadership position and ensuring operational excellence.”

About Apixio Inc.

Apixio is a leader in applying Big Data technology to extract and analyze unstructured and coded clinical data to derive outcome- and cost-related insights. Based in Silicon Valley, Apixio offers solutions that enable health plans and large provider groups to more accurately and efficiently determine member risk scores for appropriate value-based reimbursement.

For more information, visit Follow us on Twitter and LinkedIn and Like Us on Facebook.

Copyright © Business Wire 2014

Jamie Urborg, 650-450-1090